Insider Shareholders with Direct Ownership of Kezar Life Sciences, Inc. (KZR)
This section provides a comprehensive overview of the insiders with direct ownership of Kezar Life Sciences, Inc. (KZR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Kezar Life Sciences, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
0 | 4,041,059 | 1,947,993 $14.8 Million | 20 |
Aug 15, 2023
Reduced 64.24%
|
|
Onyx Therapeutics, Inc.
> 10% Shareholder |
1,121,384 | 0 | 1,121,384 $8.54 Million | 1 |
Jun 25, 2018
Added 50.0%
|
106,688 | 0 | 890,691 $6.79 Million | 4 |
Mar 21, 2022
Added 2.2%
|
|
82,010 | 0 | 431,348 $3.29 Million | 2 |
Jul 20, 2023
Added 10.19%
|
|
50,700 | 0 | 393,904 $3 Million | 3 |
Nov 10, 2022
Added 6.41%
|
|
5,000 | 5,000 | 63,690 $485,317 | 2 |
Jan 03, 2022
Reduced 7.28%
|
|
Mark C. Schiller
Chief Legal Officer |
0 | 6,688 | 33,007 $251,513 | 1 |
Jul 02, 2024
Reduced 16.85%
|
Vassiliki Economides
SVP, Strategy & External Aff. |
750 | 0 | 11,320 $86,258 | 1 |
May 30, 2019
Added 6.21%
|